TRI476B
Drug
Novartis Pharma AG
Total Payments
$75,000
Transactions
1
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $75,000 | 1 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $75,000 | 1 | 100.0% |
Top Doctors Receiving Payments for TRI476B
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Clinical Genetics (M.D.) | Boston, MA | $75,000 | 1 |
Ad
Manufacturing Companies
- Novartis Pharma AG $75,000
Product Information
- Type Drug
- Total Payments $75,000
- Total Doctors 1
- Transactions 1
About TRI476B
TRI476B is a drug associated with $75,000 in payments to 1 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2017. In 2017, $75,000 was paid across 1 transactions to 1 doctors.
The most common payment nature for TRI476B is "Royalty or License" ($75,000, 100.0% of total).